Report Detail

Pharma & Healthcare Global Prothrombin Complex Concentrate(PCC) Market Insights, Forecast to 2028

  • RnM4426730
  • |
  • 26 April, 2022
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Summary:

Market Analysis and Insights: Global Prothrombin Complex Concentrate(PCC) Market
Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.
Due to the COVID-19 pandemic, the global Prothrombin Complex Concentrate(PCC) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100IU accounting for % of the Prothrombin Complex Concentrate(PCC) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hopistial segment is altered to an % CAGR throughout this forecast period.
China Prothrombin Complex Concentrate(PCC) market size is valued at US$ million in 2021, while the US and Europe Prothrombin Complex Concentrate(PCC) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prothrombin Complex Concentrate(PCC) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, Biotest, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, WEIGUANG BIOLOGICAL, Green Cross and BOHUI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Segment by Application
Hopistial
Clinic
Others
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Prothrombin Complex Concentrate(PCC) market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
Frequently Asked Questions
Which is the most lucrative product segment in the Prothrombin Complex Concentrate(PCC) market?
Which are the prominent strategies of the Prothrombin Complex Concentrate(PCC) market players?
Which factors are increasing the competition in the Prothrombin Complex Concentrate(PCC) market?
Which are the recommendations provided by the Prothrombin Complex Concentrate(PCC) industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Prothrombin Complex Concentrate(PCC) market growth?
Which product segment will register the fastest growth rate in the Prothrombin Complex Concentrate(PCC) market?
Which emerging trends will impact the Prothrombin Complex Concentrate(PCC) market growth?
Which are the high-impact rendering factors in the Prothrombin Complex Concentrate(PCC) market?
Which companies will maintain their lead on the Prothrombin Complex Concentrate(PCC) market?


Table of Contents

    1 Study Coverage

    • 1.1 Prothrombin Complex Concentrate(PCC) Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Prothrombin Complex Concentrate(PCC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 100IU
      • 1.2.3 200IU
      • 1.2.4 300IU
      • 1.2.5 400IU
      • 1.2.6 1000IU
    • 1.3 Market by Application
      • 1.3.1 Global Prothrombin Complex Concentrate(PCC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hopistial
      • 1.3.3 Clinic
      • 1.3.4 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Prothrombin Complex Concentrate(PCC) Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Prothrombin Complex Concentrate(PCC) Sales by Region
      • 2.4.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2017-2022)
      • 2.4.2 Global Sales Prothrombin Complex Concentrate(PCC) by Region (2023-2028)
    • 2.5 Global Prothrombin Complex Concentrate(PCC) Revenue by Region
      • 2.5.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2017-2022)
      • 2.5.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Prothrombin Complex Concentrate(PCC) Sales by Manufacturers
      • 3.1.1 Global Top Prothrombin Complex Concentrate(PCC) Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prothrombin Complex Concentrate(PCC) in 2021
    • 3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers
      • 3.2.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Prothrombin Complex Concentrate(PCC) Revenue in 2021
    • 3.3 Global Prothrombin Complex Concentrate(PCC) Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Prothrombin Complex Concentrate(PCC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Prothrombin Complex Concentrate(PCC) Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type
      • 4.1.1 Global Prothrombin Complex Concentrate(PCC) Historical Sales by Type (2017-2022)
      • 4.1.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
    • 4.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type
      • 4.2.1 Global Prothrombin Complex Concentrate(PCC) Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
    • 4.3 Global Prothrombin Complex Concentrate(PCC) Price by Type
      • 4.3.1 Global Prothrombin Complex Concentrate(PCC) Price by Type (2017-2022)
      • 4.3.2 Global Prothrombin Complex Concentrate(PCC) Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application
      • 5.1.1 Global Prothrombin Complex Concentrate(PCC) Historical Sales by Application (2017-2022)
      • 5.1.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
    • 5.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application
      • 5.2.1 Global Prothrombin Complex Concentrate(PCC) Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
    • 5.3 Global Prothrombin Complex Concentrate(PCC) Price by Application
      • 5.3.1 Global Prothrombin Complex Concentrate(PCC) Price by Application (2017-2022)
      • 5.3.2 Global Prothrombin Complex Concentrate(PCC) Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Prothrombin Complex Concentrate(PCC) Market Size by Type
      • 6.1.1 North America Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
      • 6.1.2 North America Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
    • 6.2 North America Prothrombin Complex Concentrate(PCC) Market Size by Application
      • 6.2.1 North America Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
      • 6.2.2 North America Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
    • 6.3 North America Prothrombin Complex Concentrate(PCC) Market Size by Country
      • 6.3.1 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
      • 6.3.2 North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Prothrombin Complex Concentrate(PCC) Market Size by Type
      • 7.1.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
      • 7.1.2 Europe Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
    • 7.2 Europe Prothrombin Complex Concentrate(PCC) Market Size by Application
      • 7.2.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
      • 7.2.2 Europe Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
    • 7.3 Europe Prothrombin Complex Concentrate(PCC) Market Size by Country
      • 7.3.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
      • 7.3.2 Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Type
      • 8.1.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Application
      • 8.2.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Region
      • 8.3.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 China Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Type
      • 9.1.1 Latin America Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
      • 9.1.2 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
    • 9.2 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Application
      • 9.2.1 Latin America Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
      • 9.2.2 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
    • 9.3 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Country
      • 9.3.1 Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
      • 9.3.2 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina

    10 Middle East and Africa

    • 10.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Type
      • 10.1.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Application
      • 10.2.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Country
      • 10.3.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 CSL
      • 11.1.1 CSL Corporation Information
      • 11.1.2 CSL Overview
      • 11.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 CSL Recent Developments
    • 11.2 Beijing Tiantan Biological Products
      • 11.2.1 Beijing Tiantan Biological Products Corporation Information
      • 11.2.2 Beijing Tiantan Biological Products Overview
      • 11.2.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 Beijing Tiantan Biological Products Recent Developments
    • 11.3 SHANGHAI RAAS
      • 11.3.1 SHANGHAI RAAS Corporation Information
      • 11.3.2 SHANGHAI RAAS Overview
      • 11.3.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 SHANGHAI RAAS Recent Developments
    • 11.4 Biotest
      • 11.4.1 Biotest Corporation Information
      • 11.4.2 Biotest Overview
      • 11.4.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 Biotest Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 Biotest Recent Developments
    • 11.5 Taibang Biologic Group
      • 11.5.1 Taibang Biologic Group Corporation Information
      • 11.5.2 Taibang Biologic Group Overview
      • 11.5.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 Taibang Biologic Group Recent Developments
    • 11.6 HUALAN BIOLOGICAL ENGINEERING
      • 11.6.1 HUALAN BIOLOGICAL ENGINEERING Corporation Information
      • 11.6.2 HUALAN BIOLOGICAL ENGINEERING Overview
      • 11.6.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
    • 11.7 WEIGUANG BIOLOGICAL
      • 11.7.1 WEIGUANG BIOLOGICAL Corporation Information
      • 11.7.2 WEIGUANG BIOLOGICAL Overview
      • 11.7.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 WEIGUANG BIOLOGICAL Recent Developments
    • 11.8 Green Cross
      • 11.8.1 Green Cross Corporation Information
      • 11.8.2 Green Cross Overview
      • 11.8.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.8.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.8.5 Green Cross Recent Developments
    • 11.9 BOHUI
      • 11.9.1 BOHUI Corporation Information
      • 11.9.2 BOHUI Overview
      • 11.9.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.9.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.9.5 BOHUI Recent Developments
    • 11.10 Guangdong Shuanglin Biopharmaceutical
      • 11.10.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
      • 11.10.2 Guangdong Shuanglin Biopharmaceutical Overview
      • 11.10.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.10.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.10.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
    • 11.11 Jiangxi Boya Bio-Pharmaceutical
      • 11.11.1 Jiangxi Boya Bio-Pharmaceutical Corporation Information
      • 11.11.2 Jiangxi Boya Bio-Pharmaceutical Overview
      • 11.11.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.11.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.11.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Prothrombin Complex Concentrate(PCC) Industry Chain Analysis
    • 12.2 Prothrombin Complex Concentrate(PCC) Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Prothrombin Complex Concentrate(PCC) Production Mode & Process
    • 12.4 Prothrombin Complex Concentrate(PCC) Sales and Marketing
      • 12.4.1 Prothrombin Complex Concentrate(PCC) Sales Channels
      • 12.4.2 Prothrombin Complex Concentrate(PCC) Distributors
    • 12.5 Prothrombin Complex Concentrate(PCC) Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Prothrombin Complex Concentrate(PCC) Industry Trends
    • 13.2 Prothrombin Complex Concentrate(PCC) Market Drivers
    • 13.3 Prothrombin Complex Concentrate(PCC) Market Challenges
    • 13.4 Prothrombin Complex Concentrate(PCC) Market Restraints

    14 Key Findings in The Global Prothrombin Complex Concentrate(PCC) Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:
      Get latest Market Research Reports on Prothrombin Complex Concentrate(PCC). Industry analysis & Market Report on Prothrombin Complex Concentrate(PCC) is a syndicated market report, published as Global Prothrombin Complex Concentrate(PCC) Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Prothrombin Complex Concentrate(PCC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,475.65
      6,951.30
      4,058.55
      8,117.10
      676,642.50
      1,353,285.00
      362,485.50
      724,971.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report